ANA Posts Abstracts to be presented at Annual Meeting
The Annals of Neurology has published the program for the 145th Annual Meeting of the American Neurological Association, with posters
Read moreResearch Alert
First results of the COVID-19 in MS Global Data Sharing Initiative suggest anti-CD20 DMTs are associated with worse COVID-19 outcomes
Background: As the COVID-19 pandemic amplifies, efforts to minimise the risk on vulnerable people are essential. People with multiple sclerosis
Read moreEvidence of an Increased Burden of Humoral Autoimmunity in the CSF and plasma of COVID-19 Patients with Comorbid Neurologic Dysfunction
Coronavirus disease 19 (COVID-19) is the most globally impactful pandemic of the past century.
Read moreComparison of COVID-19 outcomes between racial groups in the COViMS registry
Background: Risk factors previously identified for worse outcomes with SARS-CoV-2 infections include older age, male sex and specific comorbid conditions.
Read moreCOVID-19 in people with MS: A large community-based study of the UK MS Register
Background: The Coronavirus Disease 2019 (COVID-19) pandemic has introduced uncertainties into the multiple sclerosis (MS) community and the focus so
Read moreInterrupting disease modifying treatment for pregnancy in multiple sclerosis – effect on disease activity and serum neurofilament light chain
Background: Pregnancy in MS typically goes along with reduced disease activity in the third trimester, followed by an increase in
Read moreNetwork analysis identifies gut bacteria associated with multiple sclerosis relapse among pediatric-onset patients
Background: Commensal gut microbes are known to affect host immune function and may be modifiable. Recent work suggests gut microbiota
Read moreBrain microstructural and metabolic alterations detected in vivo at the onset of the first demyelinating event
Background: In early multiple sclerosis, a clearer understanding of normal-brain tissue microstructural and metabolic abnormalities will provide valuable insights into
Read moreNeutrophil granulocyte markers in cerebrospinal fluid differentiate NMOSD and anti-MOG antibody associated disease from MS in acute disease phase
Background: Neuromyelitis optica spectrum disorders (NMOSD), anti-MOG-antibody associated disease (MOGAD) and multiple sclerosis (MS) may be difficult to differentiate. Detection
Read morePhase 2 clinical trial evidence that a retinoid-X receptor agonist promotes remyelination in people with relapsing-remitting multiple sclerosis
Background: Retinoid acid X receptor [RXR] gamma agonists promote oligodendrocyte progenitor cell differentiation and remyelination following experimental demyelination. Objectives: To
Read morePrimary astrocytopathy has a detrimental effect on remyelination efficacy of parenchymal oligodendrocyte precursor cells
Background: Astrocytic impairment is a common feature of neuromyelitis optica and possibly also multiple sclerosis (MS) lesions and initiates even
Read moreClinical Characteristics and Outcomes in Patients with Coronavirus Disease 2019 and Multiple Sclerosis
Background: Risk factors associated with the severity of COVID-19 in patients with multiple sclerosis (MS) begin to be identified from
Read more